The pill, Truvada, combines two AIDS drugs and people who take it are 86 percent less likely to get HIV, according to the study.
An HIV prevention pill, called Truvada, taken by gay men before and after sex reduced the risk of virus transmission by 86 percent, according to the results of a clinical trial.
(Getty/AFP/Justin Sullivan)
An HIV prevention pill, called Truvada, taken by gay men before and after sex reduced the risk of virus transmission by 86 percent, according to the results of a clinical trial.
(Getty/AFP/Justin Sullivan)
A study has shown that a pill currently being
used to treat HIV could serve to prevent the disease if taken before and
after unprotected sex.
The pill, Truvada, combines two AIDS drugs and people who take it are 86 percent less likely to get HIV.
The
study, done in France and Canada, was conducted on 400 gay men who
were given fake or real Truvada and told to take two pills from two to
24 hours before sex, a third pill 24 hours later, and a fourth pill 48
hours after the first dose. The men also were given condoms and disease
prevention counseling.
The study was stopped in
November 2014 after researchers saw that the drug was working with
nausea and diarrhoea being the only major side effects.
During the duration of the study, only two men, who stopped using the pills after more than a year, were infected with HIV.
"That impressed me," Dr Scott Hammer, an AIDS specialist at Columbia University in New York said.
Dr Susan Buchbinder,
an AIDS specialist at the San Francisco Department of Public Health,
said the results were exciting but warned that they might not apply to
male-female sex, because different types of sex expose partners to
differing amounts of virus.
The study of Gilead Science's Truvada was led by the French national HIV research agency.
No comments:
Post a Comment